Chong Kun Dang Pharmaceutical (185750) — Financial Flexibility Index
Chong Kun Dang Pharmaceutical (185750) has a Financial Flexibility Index of 0.11x as of March 2026. Free cash flow of ₩86.65 Billion (operating CF ₩12.32 Billion minus capex ₩74.34 Billion) represents 0% of total liabilities (₩803.02 Billion). Check 185750 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chong Kun Dang Pharmaceutical Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Chong Kun Dang Pharmaceutical across 10 annual periods. For the full cash flow conversion analysis, see Chong Kun Dang Pharmaceutical (185750) cash flow conversion.
Annual Financial Flexibility Index for Chong Kun Dang Pharmaceutical (2016–2025)
Year-by-year free cash flow to debt coverage for Chong Kun Dang Pharmaceutical. Explore 185750 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | ₩246.49 Billion | ₩67.36 Billion | ₩793.94 Billion | ▲ +33.9% |
| 2024 | 0.23x | ₩130.39 Billion | ₩64.29 Billion | ₩562.39 Billion | ▼ -64.8% |
| 2023 | 0.66x | ₩386.97 Billion | ₩318.16 Billion | ₩586.79 Billion | ▲ +194.9% |
| 2022 | 0.22x | ₩112.63 Billion | ₩67.73 Billion | ₩503.59 Billion | ▲ +75.9% |
| 2021 | 0.13x | ₩61.15 Billion | ₩12.90 Billion | ₩480.89 Billion | ▼ -63.4% |
| 2020 | 0.35x | ₩136.96 Billion | ₩104.32 Billion | ₩394.74 Billion | ▲ +14.2% |
| 2019 | 0.30x | ₩99.13 Billion | ₩77.29 Billion | ₩326.40 Billion | ▲ +32.0% |
| 2018 | 0.23x | ₩64.54 Billion | ₩42.63 Billion | ₩280.60 Billion | ▼ -37.9% |
| 2017 | 0.37x | ₩101.46 Billion | ₩81.67 Billion | ₩273.91 Billion | ▲ +9.5% |
| 2016 | 0.34x | ₩97.23 Billion | ₩57.79 Billion | ₩287.45 Billion | — |